Phase 3 study of SC vs IV daratumumab in patients with relapsed or refractory multiple myeloma International Myeloma Foundation 5:20 5 years ago 308 Далее Скачать
Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma International Myeloma Foundation 5:00 6 years ago 1 776 Далее Скачать
Subcutaneous daratumumab show benefit in patients with relapsed or refractory multiple myeloma ecancer 1:33 6 years ago 107 Далее Скачать
SC daratumumab deemed feasible for every multiple myeloma patient MDedge: news and insights for busy physicians 4:42 5 years ago 995 Далее Скачать
Subcutaneous versus intravenous daratumumab administration in patients with relapsed or refracto... ecancer 7:00 5 years ago 162 Далее Скачать
IV daratumumab in R/R myeloma: bodyweight analysis VJHemOnc – Video Journal of Hematology & HemOnc 3:56 4 years ago 58 Далее Скачать
COLUMBA: subcutaneous daratumumab vs. IV administration VJHemOnc – Video Journal of Hematology & HemOnc 4:59 5 years ago 1 243 Далее Скачать
SC daratumumab plus standard-of-care regimens in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:05 3 years ago 154 Далее Скачать
Evaluating Teclistamab in Relapsed and/or Refractory Multiple Myeloma International Myeloma Foundation 8:12 4 years ago 724 Далее Скачать
Columba study update: subcutaneous daratumumab in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:03 5 years ago 225 Далее Скачать
KdD vs. Kd for the Treatment of Relapsed or Refractory Multiple Myeloma (Phase 3 Study Cando) Oncoletter 7:03 5 years ago 173 Далее Скачать
Subcutaneous Daratumumab in R/R Myeloma: The COLUMBA Trial OncLive 3:48 5 years ago 1 156 Далее Скачать
Daratumumab Safe in Relapsed/Refractory Multiple Myeloma Patients American Society of Hematology 10:16 9 years ago 866 Далее Скачать
Results of Iberdomide in Combination with Dex and Daratumumab or Bortezomib in Patients with RRMM International Myeloma Foundation 6:14 4 years ago 438 Далее Скачать
Alnuctamab, a BCMA x CD3 T-Cell Engager, in Pts with Relapsed/Refractory Multiple Myeloma International Myeloma Foundation 8:36 1 year ago 577 Далее Скачать
Daratumumab shows remarkable benefit in relapsed or refractory multiple myeloma in the POLLUX trial VJHemOnc – Video Journal of Hematology & HemOnc 5:36 8 years ago 172 Далее Скачать
Dr. Martin on Subcutaneous Administration of Daratumumab in Multiple Myeloma OncLive 0:49 5 years ago 792 Далее Скачать
Should Frontline Myeloma Treatment Include a 3- or 4-Drug Regimen? Targeted Oncology 1:02 4 years ago 767 Далее Скачать
Elranatamab in Combination with Daratumumab for Pts with RRMM: Phase 3 MagnetisMM-5 International Myeloma Foundation 9:07 1 year ago 548 Далее Скачать
Daratumumab + Pomalidomide & Dexamethasone Effective in Relapsed/Refractory Multiple Myeloma CheckRare 5:03 4 years ago 525 Далее Скачать
